New Study Reveals AI Mapping Technology, Unfold AI, Outperforms MRI in Predicting Prostate Cancer Spread Provided by PR Newswire May 1, 2025, 6:04:00 AM ...

More information: Charlie A. Hamm et al, Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer, JAMA Oncology (2024). DOI: 10.1001/jamaoncol.2024.5497 ...

Grade Group ≥2 prostate cancer was detected in 57 of 121 patients in the microultrasonography group, 141 of 331 patients in the MRI/US-fusion group, and 106 of 226 in the MRI ...

*Hamm C. A. et al. Oncological Safety of MRI-Informed Decision-Making in Men With Suspected Prostate Cancer. JAMA Oncol. Dec. 12 2024, doi: 101001/jamaoncol.2024.5497 ...

TOPLINE: High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6% ...

AI-driven MRI analysis offers new insights into prostate cancer prognosis, accurately predicting metastasis risk and treatment outcomes for improved patient care. Study: AI-derived Tumor Volume ...

The researchers wanted to determine if high-resolution micro-ultrasonography-guided biopsy was better than MRI fusion-guided biopsy for detecting prostate cancer in a clinical setting. The study found ...

Send comments and news tips to uknewsdesk@medscape.co.uk. Cite this: MRI-Based Active Surveillance Shows Promise in Prostate Cancer Risk Stratification - Medscape - June 06, 2025.

Put another way, using the MRI-targeted approach would spare 51 men from undergoing biopsy and 14 men from receiving grade 1 prostate cancer diagnoses out of every 1,000 men.

After a median follow-up of 3.9 years (approximately 26,000 person-years in each group), prostate cancer had been detected in 185 of the 6575 men (2.8%) in the MRI-targeted biopsy group and 298 of ...

Over approximately 26,000 person-years, any prostate cancer (2.8% vs 4.5%) and clinically insignificant grade group 1 prostate cancer (1.0% vs 2.4%) were detected in lower proportions of the MRI ...

Source Reference: Kinnaird A, et al "Microultrasonography-guided vs MRI-guided biopsy for prostate cancer diagnosis: the OPTIMUM randomized clinical trial" JAMA 2025; DOI: 10.1001/jama.2025.3579.